A comparison of insulin aspart and regular insulin in elderly patients with type 2 diabetes

Diabetes, Obesity and Metabolism

Volumn 9, Issue 5, 2007, Pages 754-755

  Meneilly, Graydon S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Elderly; Insulin aspart; Regular insulin; Type 2 diabetes

Indexed keywords

ENSURE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; METFORMIN; NOVOLIN R; UNCLASSIFIED DRUG;

AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACODYNAMICS; RANDOMIZED CONTROLLED TRIAL; TIME SERIES ANALYSIS;

EID: 34547858122     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2006.00639.x     Document Type: Article

References (6)

1. Hirsch IB. Insulin analogues. New Eng J Med 2005; 352: 174-83.
2. Meneilly GS, Tessier D. Diabetes in elderly adults. J Gerontol 2001; 56A: M5-M13.
3. Meneilly GS, Veldhuis JD, Elahi D. Disruption of the pulsatile and entropic modes of insulin release during an unvarying glucose stimulus in elderly individuals. J Clin Endocrinol Metab 1999; 84: 1938-1943.
4. Mudaliar SR, Strange P, Lindberg FA et al. Insulin aspart (B28 asp-insulin): A fast-acting analog of human insulin. Diabetes Care 1999; 22: 1501-1506.
5. Osterberg O, Erichsen L, Ingwersen SH, Plum A, Poulsen HE, Vicini P. Pharmacokinetic and pharmacodynamic properties of insulin aspart and human insulin. J Pharmacokinet Pharmacodyn 2003; 30: 221-235.
6. Chang AM, Halter JB. Aging and insulin secretion. Am J Physiol 2003; 284: E7-E12.